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Abstract
Background: Inflammation process plays an important role in the development of atherosclerosis.
Hypercholesterolemia is one of the major risk factors for atherosclerosis. The present study aimed to evaluate the
effect of aqueous extract of Piper sarmentosum (P.s) on inflammatory markers like vascular cell adhesion molecule-1
(VCAM-1), intercellular adhesion molecule-1 (ICAM-1), and C-reactive protein (CRP).
Methods: Forty two male New Zealand white rabbits were divided equally into seven groups; (i) C- control group
fed normal rabbit chow (ii) CH- cholesterol diet (1%cholesterol) (iii) X1- 1% cholesterol with water extract of P.s
(62.5 mg/kg) (iv) X2- 1% cholesterol with water extract of P.s (125 mg/kg (v) X3- 1% cholesterol with water extract
of P.s (250 mg/kg) (vi) X4- 1% cholesterol with water extract of P.s (500 mg/kg) and (vii) SMV group fed with 1%
cholesterol supplemented with simvistatin drug (1.2 mg/kg). All animals were treated for 10 weeks. Blood serum
was taken for observing the inflammatory markers at the beginning and end of the experiment.
Results: Rabbits fed with 1% cholesterol diet (CH) showed significant increase in the level of VCAM-1, ICAM-1 and
CRP compared to the C group. The levels of VCAM-1, ICAM-1 and CRP in the 1% cholesterol group and
supplemented with P.s (500 mg/kg) were significantly reduced compared to the cholesterol group. Similar results
were also reported with simvistatin group.
Conclusion: These results suggest that the supplementation of Piper sarmentosum extract could inhibit
inflammatory markers which in turn could prevent atherosclerosis.
Background
Inflammation is a major pathophysiological mechanism
in atherosclerosis [1]. Histopathologically, atherosclerosis
is characterized by a thickening of the vascular wall due
to lipid accumulation and infiltration of macrophages
and lymphocytes [2,3]. Many evidences have indicated
the presence of many cell adhesion molecules and
growth factors in atherosclerosis. Other reports have
stressed that there are interactions between the adhesion
molecules and growth factors in inflammatory
responses. Researches have shown that the development
of atherosclerosis is caused by a complex interaction
between reactive oxygen species, lipids, endothelium,
circulation and tissue inflammatory cells, platelets and
vascular smooth muscle cells and was not simply due to
the accumulation of lipids [4,5].
Hypercholesterolemia is one of the most important
risk factors for atherosclerosis and related occlusive vas-
cular disease [6]. Recent observations suggest that the
endothelium’s dysfunction and inflammation cause not
only the initial stage of the atherosclerotic process but
also atherosclerotic plaque development.
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lular adhesion molecule ICAM-1 are endothelial adhe-
sion molecules of the Ig gene superfamily that may
participate in atherogenesis by promoting monocyte
accumulation in the arterial intima [7]. Elevated levels of
inflammatory markers, especially CRP, are associated
with an increased risk of cardiovascular disease [1,8,9].
Serum CRP stimulates endothelial cell expression of
( I C A M - 1 )a n d( V C A M - 1 )[ 1 0 ] .T h eI C A M - 1a n d
VCAM-1 are important factors in the development of
atherosclerosis and may play an important role in pro-
moting the local inflammation within the atherosclerotic
plaque [11]. Cellular adhesion molecules like ICAM-1
and VCAM-1 are involved in the rolling, adhesion and
extravasation of monocytes and T-lymphocytes [12-14].
This migration is one of the earliest events in the athero-
sclerotic process in addition to its later contribution to
the chronic inflammatory process. Pathological studies of
human atherosclerosis have shown increased expression
of CAMs located in endothelial cells. Increased levels of
soluble (s) forms of CAMs in circulating blood have been
found in a number of conditions with an inflammatory
component [15,16]. Various studies have showed there
are many inflammatory markers that can predict cardio-
vascular events, including cell adhesion molecules, cyto-
kines, chemokines, acute phase reactants such as
fibrinogen, serum amyloid A and CRP. Additionally, CRP
which has recently emerged as one of the most important
inflammatory mediators can directly participate in the
pathogenesis of atherosclerosis by activating endothelial
cells and promoting the inflammatory component of
atherosclerosis [2,3]. CRP plays a crucial role in the
pathogenesis of the vascular inflammatory process which
is abrogated by simvastatin therapy. In this study we
focus on the effect of natural antioxidant on inflamma-
tory markers, ICAM-1, VCAM-1 and CRP. The results of
the present study may help in the prevention and treat-
ment of atherosclerosis. Research in herbal medicine can
provide an alternative solution to health problems.
Piper sarmentosum belongs to the family Piperaceae.I n
different parts of the world, P.s has been used traditionally
to cure many diseases [17]. Phytochemically, the plant
contains constituents like alkaloids (amide, flavonoids, pyr-
ones) [18] and it has also been reported to possess phar-
macological properties like antituberculosis [19] anti-
cancer [20], anti-angiogenic [21], anti-diabetic [22], anti-
malarial [23], antioxidant [24], neuromuscular blocker [25]
and antiamoebic [26]. Previous study has indicated that
aqueous extract of Piper sarmentosum may improve
endothelial function by promoting NO production in
HUVECs [27] and our previous study indicated that Ps
can be reduce atherosclerosis lesion [28]. Piper sarmento-
sum has flavonoids compounds which are widely distribu-
ted in plants which have been reported to have
antioxidant, free radical scavenging abilities and anti-
inflammatory effect [29]. The active extract of P. sarmento-
sum contains natural antioxidants like Naringenin (75.7%),
Hesperitin (91.7%), Taxifolin/Dihydroquercitin (90.9%)
and Quercetin (98.1%) which have high superoxide
scavenging action [24].. The antioxidant activities of phy-
nolic compounds like flavonoid which have anti-inflamma-
tory action by inhibiting IL6 and TNF and inhibits the
aggregation and adhesion of platelets in the blood [30]. It
has been also shown that flavonoids reduce LDL oxidation,
which is an important step in atherogenesis [31].
Materials and methods
Animals and experimental protocol
This study was approved by the Animal Ethics Commit-
tee, Universiti Kebangsaan Malaysia. Forty two male
New Zealand White rabbits average body weight
between 1.8 ± 2 kg were purchased from East Asia Rab-
bit Corporation Sdn. Bhd. Malaysia. The animals were
housed separately in cages in an air-conditioned room
with a 12-h light/dark cycle. All animals had free access
to water. The rabbits were divided randomly into seven
groups; control group (C; n = 6) was fed the rabbit
chow, cholesterol group (CH; n = 6) was fed the similar
diet enriched with 1% cholesterol, experimental groups
(X1;n = 6, X2; n = 6, X3; n = 6 and X4; n = 6), were fed
with similar diet enriched with 1% cholesterol plus dif-
ferent doses of water extract of P.s (62.5, 125, 250 and
500 mg/kg/day) respectively. The simvistatin group
(Smv; n = 6) was fed with the standard diet mixed with
1% cholesterol plus simvistatin drug (1.2 mg/kg/day,
Merck, NJ) [32]. The experiment was continued till 10
weeks. The blood sample was taken at the beginning of
the study and the end of the study via the marginal ear
vein. At the end of 10 weeks, the animals were fasted
overnight and sacrificed by intravenous injection of pen-
tobarbital (Nembutal, Abbott Laboratories, North Chi-
cago, IL, 50 mg/kg body weight) and the abdominal
aortic tissue was collected for histological studies.
Preparation of the aqueous extract of P.s extract
The aqueous extract of P.s leaves were extracted in the
laboratory of Furley Marketing Sdn, Bhd, Malaysia. The
freeze dried powdered extract was prepared after that in
the laboratory of Faculty of Pharmacy, Universiti
Kebangsaan Malaysia, where the powdered extract was
stored in dark bottles and kept in 4°C until used. The
administration dose powder was mixed with 5 ml of
water to dissolve and given to rabbits as oral dose by
special needle.
High cholesterol diet
Cholesterol powder was purchased from (Sigma Chemi-
cal Co., St. Louis, USA), it was mixed with the rabbit
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each 200 g of grounded rabbit chow pellet, 2 g of cho-
lesterol was added and mixed with a 34 ml of chloro-
form where cholesterol was dissolved in 99.9%
chloroform and then mixed with grounded rabbit chow
pellet. Chloroform was evaporated by exposing the diets
as a thin layer at 50°C in oven [33].
Diphenylpicrylhydrazyl (DPPH) for estimating antioxidant
activity
1, 1-Diphenyl-2-picryl-hydrazyl (DPPH) was purchased
from Sigma (USA). Ascorbic acid was purchased from
Sigma USA. To measure antioxidant activity, the
(DPPH), radical-scavenging assay was carried according
to previous method [34,35] with slight modification.
Briefly the DPPH 500 μm stock solution was prepared
by adding 19.716 mg of DPPH to 100 ml of methanol
and mixed until the purple colour appeared. The stock
solution of vitamin C was used as positive control and
sample were prepared (1000 mg/ml) with different dilu-
tion (500, 200,100, 50, 25, 12.5 and 0 mg/ml). The
DPPH was mixed with the sample and vitamin C and all
the tubes were left in room temperature for 30 mins in
the dark. The colour was read at the absorbance at 515
nm against blank samples and the calculations of the
scavenging effect (%) are as follows:
Scavenging effect (%)
    
 
=−
− ⎛
⎝
1
A sample A sample blank
A control ⎜ ⎜
⎞
⎠
⎟×100
A control = Abs of DPPH solution without sample
Asample = DPPH solution sample
Asample blank= sample without DPPH
T h ed a t ai sc o m m o n l yr e p o r t e da sI C 50,w h i c hi st h e
concentration of antioxidant required for 50% scaven-
ging of DPPH radicals in the specified time period
Evaluation of Plasma Circulatory Markers (VCAM-1) and
(sICAM-1)
The level concentrations of circulating Rabbit Soluble
Intercellular Adhesion Molecule-1 (sICAM-1) and solu-
ble vascular cell adhesion molecule 1(VCAM-1) were
measured using Rabbit Enzyme-Linked Immunosorbent
Assay (ELISA) and a commercially available kit (Uscn
Life Science & technology company, USA) according to
the manufacturer’s instructions. Values of samples were
calculated from a standard curve generated from stan-
dards of known concentration. Absorbance at 450 nm
was determined using VERSA microplate reader (USA).
Measurement of Plasma Rabbit High-Sensitive C - reactive
protein by Enzyme-Linked Immunosorbent Assay (ELISA)
The quantification CRP level in plasma was determined
using rabbit high-sensitive CRP ELISA kits from Kamiya
Biomedical (Seattle, WA). The results was calibrated by
the the software calculation that was provided with the
VERSA microplate reader (USA) and compared to the
calibration standard curve.
Statistical analysis
Statistical analysis was carried out using the SPSS statis-
tical package version 18 (SPSS Inc. USA). Distribution
of data was examined by Kolmogrov-Smirnov test and
found to be normal. Paired t-test was used to compare
between 0 time and end time in the same group and
ANOVA test was used to compare between the groups.
Results
(DPPH) for estimating antioxidant activity
The result showed the DPPH radical-scavenging activity
of the water extract has high antioxidant activities (Fig-
ure 1) indicated by the increase in the concentration of
the sample. The antioxidant activities of the IC 50 sca-
venger activity of water extract was 27.12 mg/ml.
Plasma Circulatory Markers (VCAM-1) and (sICAM-1) and
CRP
There was no significant difference in ICAM-1, VCAM-
1 and CRP levels between 0 time and end time of
experiment in the control group (C). In the athero-
sclerosis group there were significant increase between 0
times and end time for all ICAM-1, VCAM-1 and CRP.
A similar finding was reported with the X1 group (62.5
mg/kg). In groups X2 and X3 (125 and 250 mg/kg),
there were also significant differences between 0 time
and end time. In groups X4 (500 mg/kg) and simvasta-
tin, there was no significant difference between the 0
times and the end time of experiment. There was also
significant increase in atherosclerotic and X1 groups as
compared to control group. There were statistically sig-
nificant reductions in the levels of ICAM-1, VCAM-1
and CRP at the end of treatment with water extract in
group 500 mg/kg compared to atherosclerosis group.
Similarly simvistatin group also showed significant
reductions in the levels of ICAM-1, VCAM-1 and CRP
compared to atherosclerosis group (Figure 2, 3, 4 and 5)
Discussion
The present study showed thatt h ew a t e re x t r a c to fP . s
has high antioxidant activities and free radical-scaven-
ging activity. The effect of antioxidants on DPPH radical
scavenging may be due to their hydrogen donating abil-
ity. The antioxidant properties of P.s were demonstrated
in previous reports [24]. In general, some antioxidants
can prevent atherosclerosis by protecting LDL from oxi-
dation and are also associated with an anti-hypercholes-
terolemic effect [36,37]. Several epidemiological studies
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Page 3 of 8Figure 1 DPPH radical scavenging activity of water extract of Ps. Observation as IC50.
Figure 2 Determination level of ICAM in the pretreatment and post treatment in the different groups. *P < 0.05 as compare to control
group.
#P < 0.05 as compare to atherosclerosis group.
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Page 4 of 8Figure 3 Determination level of VCAM in the pretreatment and post treatment in the different groups. *P < 0.05 as compare to control
group.
#P < 0.05 against atherosclerosis group.
Figure 4 Determination level of CRP in the pretreatment and post treatment in the different groups. *P < 0.05 as compare to control
group.
#P < 0.05 against atherosclerosis group.
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antioxidants correlates with reduced coronary heart dis-
ease. Food rich in antioxidants plays an essential role in
the prevention of cardiovascular diseases [38,39]. The
extract compounds of P.s contains active compound like
Naringenin(75.7%), Hesperitin (91.7%), Taxifolin/Dihy-
droquercitin(90.9%) and Quercetin (98.1%) which have
high superoxide scavenging action [24]. However, there
are no research reports on the effect of P.s on inflamma-
tory markers in rabbits given cholesterol diet. The con-
sumption of a cholesterol enriched diet increases the
degree of lipid peroxidation, which is also one of the
early processes involved in atherosclerosis.
After 10 weeks of treatment with water extract of P.s
together with high cholesterol diet, the present study
showed that ICAM, VCAM-1 and CRP levels were sig-
nificantly decreased compared to rabbits given a high
cholesterol diet. This study showed that treatment with
this extract at the dose 500 mg/kg and simvistatin
group can decrease the rise in ICAM-1, VCAM-1 and
CRP. The mechanism of P.s in reducing the inflamma-
tory markers is still unknown but this result suggests
that this extract may have an antioxidant effect on
inflammatory markers in rabbits given cholesterol diet.
A previous study showed significant decreased levels of
CRP in dyslipidemic patients with coronary artery dis-
ease treated with simvastatin 20 mg per day for 4
months [40]. Another study indicated that CRP-
mediated inflammation is inhibited by simvastatin [39].
Previous studies showed that the elevated levels of CRP
are associated with an increased risk of cardiac events
[42-44]. We observed a significant increase in circulat-
ing VCAM-1, ICAM-1 levels when fed the cholesterol
diet in rabbits. Increased levels of cell adhesion mole-
cules in blood from patients with atherosclerosis have
been observed in previous studies [45,46], supporting
t h et h e o r yt h a ts o l u b l ei n flammatory markers are
involved in the pathophysiology of atherosclerosis. Pro-
spective epidemiological studies have shown increased
cardiovacsular risk associated with increased basal levels
of soluble ICAM-1, VCAM-1, P-selectin, and E-selectin
[47-50].
Atherosclerosis, which is a chronic inflammatory dis-
ease of arteries, is characterized by a thickening of the
Figure 5 Effect of ICAM, VCAM and CRP between the different groups. *P < 0.05 as compare to control group.
#P < 0.05 against
atherosclerosis group.
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lymphocytes. In animals with diet-induced or genetically
determined hyperlipidemia, the earliest morphological
changes in arteries include focal adherence of mononuc-
lear leukocytes to the endothelium and accumulation of
monocyte-derived foam cells in the intima [51,52].
The mechanisms that link diet-induced hyperlipidemia
in the evolution of cellular changes in the arterial wall
still remain poorly understood. VCAM-1 expression
might conceivably result from macrophage accumulation
because activated macrophages can produce many of the
cytokines known to stimulate endothelial VCAM-1
expression [53]. Oxidative stress induced inflammatory
responses cause damage to the vasculature and may play
an important role in the development of many diseases
including atherosclerosis [54]. Activation of endothelial
cells by oxidants may lead to a wide range of functional
changes such as an increased expression of VCAM-1,
ICAM-1, and E-selectin, and the production of chemo-
kines, such as monocyte chemoattractant peptide-1. The
resulting attraction and transendothelial migration of
monocytes are believed to be critical to the initiation
and progression of atherosclerosis [55]. The protective
effect of antioxidant is still not clear but it may serve as
ap r o t e c t i v ef u n c t i o nb yp r e venting the oxidation of
LDL.
Conclusion
This study suggests that hypercholesterolemic athero-
sclerosis is associated with an increase in inflammatory
markers and that Piper sarmentosum is effective in redu-
cing the inflammation which is important in the process
of atherosclerosis.
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